AngioDynamics (ANGO) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.16 per share a year ago. These ...

M revenue in 2025 with strong margins, military contracts, and Palantir collaboration. Click to read why RCAT is a Strong Buy ...

Equities researchers at Seaport Res Ptn decreased their Q1 2025 earnings per share estimates for shares of International ...

Evolution AB's revenue growth in North America is strong, but Asia's stagnation and unresolved cyberattacks pose challenges.